The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sobko E.A.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia;
Territorial Clinical Hospital, Krasnoyarsk, Russia

Chubarova S.V.

Prof. V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia;
Territorial Clinical Hospital, Krasnoyarsk, Russia

Demko I.V.

GBOU VPO "Krasnoiarskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. prof. V.F. Voĭno-Iasenetskogo" Minzdrava Rossii

Loktionova M.M.

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia;
Krasnoyarsk Territorial Hospital, Krasnoyarsk, Russia

Ishchenko O.P.

Territorial Clinical Hospital, Krasnoyarsk, Russia

Solovyeva I.A.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia

Kraposhina A.Yu.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia

Gordeeva N.V.

Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia;
Krasnoyarsk Territorial Hospital, Krasnoyarsk, Russia

ACOS: Clinical and functional features The Russian formulation mesalazine (kansalazine) in the therapy of ulcerative colitis

Authors:

Sobko E.A., Chubarova S.V., Demko I.V., Loktionova M.M., Ishchenko O.P., Solovyeva I.A., Kraposhina A.Yu., Gordeeva N.V.

More about the authors

Journal: Therapeutic Archive. 2017;89(12): 68‑75

Read: 6815 times


To cite this article:

Sobko EA, Chubarova SV, Demko IV, et al. . ACOS: Clinical and functional features The Russian formulation mesalazine (kansalazine) in the therapy of ulcerative colitis. Therapeutic Archive. 2017;89(12):68‑75. (In Russ.)
https://doi.org/10.17116/terarkh2017891268-75

References:

  1. DeMarco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, Casali L, Ferrari M, Nicolini G, Panico MG, Pirina P, Zanolin ME, Cerveri I, Verlato G. The coexistence of asthma and chronic obstructivepulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985. https://doi.org/10.1371/journal.pone.0062985
  2. Ovcharenko S. Phenotypes of chronic obstructive pulmonary disease and the ECLIPSE study: preliminary results. Pul’monologiya. 2011;3:113-117. (In Russ.)
  3. Diagnosis of disease of chronic airflow limitation: asthma, COPD and asthma—COPD overlap syndrome (ACOS). Аccessed November 5, 2015. http://www.goldcopd.org/asthma—COPDoverlap.html
  4. Zeki A, Schivo M, Chan A, Albertson T, Louie S. The asthma-COPD overlap syndrome: A common clinical problem in the elderly. Journal of Allergy. 2011;2011:861926. https://doi.org/10.1155/2011/861926
  5. Belevskii А. Overlap syndrome of asthma and chronic obstructive pulmonary disease (based on a joint working document GINA and GOLD expert groups. Prakticheskaya pul’monologiya. 2014;2:12-19. (In Russ.)
  6. Leshchenko I, Baranova I. Inflammatory biomarkers in chronic obstructive pulmonary disease. Pul’monologiya. 2012;2:108-117. (In Russ.)
  7. Savushkina O, Chernyak A. Theoretical and methodological aspects of body plethysmography and clinical applications. Bûlleten’ fiziologii i patologii dyhaniâ. 2016;60:117-124. (In Russ.) https://doi.org/10.12737/20131
  8. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of COPD. 2014. Accessed October 20, 2014. http://www.goldcopd.org/
  9. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, Pataka A, Tsakiridis K, Arikas S, Mpakas A, Tsiouda T, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Siminelakis S, Kolettas A, Kessis G, Beleveslis T, Zarogoulidis K. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6:146-151. https://doi.org/10.3978/j.issn.2072-1439.2014. 03.04
  10. Tetenev K, Tetenev F, Ageyeva T, Bodrova T, Karzilov A, Mesko P. Mechanisms of counteracting flap-valve bronchial obstruction in case of obstructive pulmonary emphysema. Byulleten’ sibirskoi meditsiny. 2015;4(14):75-81. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.